Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Schedule regular follow-ups
Market Segmentation Global Glucagon-Like Peptide-1 Agonists Market Size, Share & Industry Analysis, By Product Type (Short-Acting GLP-1 Agonists, Long-Acting GLP-1 Agonists), By Route of Administration (Injectable, Oral), By Application (Type 2 Diabetes, Obesity Management, Cardiovascular Disease Management), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Analysis and Forecast 20262035 Global Glucagon-Like Peptide-1 Agonists Market Size & Statistics The Market size of global glucagon-like peptide-1 agonists was estimated to be worth USD 46.18 Billion in 2025
doi: 10.1530/EC-17-0015 24 GasbjergLSRasmussenRSLangbergLSstergaardFVestergaardMBAsmarAet al
Farsad, P
Stephen Matta is a leader in the field of regenerative medicine , offering personalized treatment plans tailored to each patients specific needs
